Diagnosis and treatment of the majority of common cardiac dis orders is based on the results of large, multicentre, randomised trials which are analysed by experts and published in the form of guidelines or recommendations of international cardiac societies. In cases of rare diseases, such methodology is impossible to imple ment due to the lack of sufficient and large‑scale data